Purely RNA

Fundamental laboratory techniques such as Northern blot analysis, RNA protection assays, in situ hybridization, and reverse transcriptase-PCR (RT-PCR) require high-quality, highly purified RNA samples. Preparing such samples is often laborious at best, because RNAses-both stable and omnipresent-can easily degrade the samples. In the past, RNA work was often left to dedicated labs, with dedicated work areas, equipment, and some very meticulous workers. Fortunately, the technology continues to evo

Written byDeborah Stull
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The first step to RNA recovery is cell lysis, which depends on the denaturation of the proteins that comprise the cellular membrane. In 1979 John Chirgwin and colleagues devised a method for disrupting cellular membranes without denaturing nucleic acids. They homogenized tissue in guanidinium thiocyanate, a protein denaturant, and b-mercaptoethanol, a reducing agent.1 These scientists then isolated and purified the cellular RNA through either ethanol extraction or ultracentrifugation across a cesium chloride gradient. This technique was the first to allow researchers to isolate RNA specifically, but it had a number of drawbacks-it was lengthy, inefficient, hazardous, and inconsistent.

In 1987 Piotr Chomczynski and Nicoletta Sacchi improved on this method by combining the extraction procedures into one step through the use of a mixture of guanidinium thiocyanate and phenol-chloroform.2 This modification had at least two tangible benefits. First, it reduced the length of the RNA-isolation step, allowing researchers to increase the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies